Generic name: NEBIVOLOL HYDROCHLORIDE 5mg
Dosage form: tablet
Drug class: Cardioselective beta blockers
Medically reviewed by Drugs.com. Last updated on Sep 15, 2021.
The dose of BYSTOLIC must be individualized to the needs of the patient. For most patients, the recommended starting dose is 5 mg once daily, with or without food, as monotherapy or in combination with other agents. For patients requiring further reduction in blood pressure, the dose can be increased at 2-week intervals up to 40 mg. A more frequent dosing regimen is unlikely to be beneficial.
In patients with severe renal impairment (ClCr less than 30 mL/min) the recommended initial dose is 2.5 mg once daily; titrate up slowly if needed. BYSTOLIC has not been studied in patients receiving dialysis [see Clinical Pharmacology (12.4)].
In patients with moderate hepatic impairment, the recommended initial dose is 2.5 mg once daily; titrate up slowly if needed. BYSTOLIC has not been studied in patients with severe hepatic impairment and therefore it is not recommended in that population [see Clinical Pharmacology (12.4)].
It is not necessary to adjust the dose in the elderly [see use in Specific Populations (8.5)].
No dose adjustments are necessary for patients who are CYP2D6 poor metabolizers. The clinical effect and safety profile observed in poor metabolizers were similar to those of extensive metabolizers [see Clinical Pharmacology (12.3)].
More about Bystolic (nebivolol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (224)
- Drug images
- Side effects
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: cardioselective beta blockers
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.